CynapseDx Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
M&A
CynapseDx General Information
Description
Operator of a molecular diagnostics firm focused on the detection of aggregated protein biomarkers. The company offers assay technology based on its proprietary high-density magnetic beads that use immobilized antibodies to scavenge disease markers from whole blood without the need for prior sample preparation, thereby enabling life science researchers to capture, concentrate and purify target cells.
Contact Information
Website
www.cynapsedx.com/about-usCorporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
Corporate Office
- Liverpool Science Park
- 131 Mount Pleasant
- Liverpool L3 5TF
- England, United Kingdom
CynapseDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 05-Apr-2021 | Completed | Generating Revenue | |||
| 2. Grant | 16-Jun-2014 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 12-Jul-2012 | $93.8K | $93.8K | Completed | Startup |
CynapseDx Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CynapseDx Patents
CynapseDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201904810-D0 | The treatment of protein aggregation diseases | Inactive | 05-Apr-2019 | ||
| WO-2020201775-A1 | The treatment of protein aggregation diseases | Inactive | 05-Apr-2019 | ||
| GB-201901663-D0 | Diagnosis of multiple systems atrophy | Inactive | 06-Feb-2019 | ||
| GB-201518675-D0 | Detection of structural forms of proteins | Inactive | 21-Oct-2015 | ||
| WO-2017067672-A1 | Detection of structural forms of proteins | Inactive | 21-Oct-2015 | G01N33/6896 |
CynapseDx Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CynapseDx Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Investment Bank | Investment Bank | Minority | ||
| European Regional Development Fund (Brandenburg) | Government | Minority | ||
| Spark Impact | Corporate Venture Capital | Minority | ||
| Technology Strategy Board (TSB) | Corporation | Minority | ||
| The North West Fund | Venture Capital | Minority |
CynapseDx FAQs
-
When was CynapseDx founded?
CynapseDx was founded in 2012.
-
Where is CynapseDx headquartered?
CynapseDx is headquartered in Liverpool, United Kingdom.
-
What is the size of CynapseDx?
CynapseDx has 1 total employees.
-
What industry is CynapseDx in?
CynapseDx’s primary industry is Biotechnology.
-
Is CynapseDx a private or public company?
CynapseDx is a Private company.
-
What is CynapseDx’s current revenue?
The current revenue for CynapseDx is .
-
How much funding has CynapseDx raised over time?
CynapseDx has raised $93.8K.
-
Who are CynapseDx’s investors?
European Investment Bank, European Regional Development Fund (Brandenburg), Spark Impact, Technology Strategy Board (TSB), and The North West Fund have invested in CynapseDx.
-
When was CynapseDx acquired?
CynapseDx was acquired on 05-Apr-2021.
-
Who acquired CynapseDx?
CynapseDx was acquired by PharmaKure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
